The exact concentration of CML-HSA in human blood is not currently known, but our previous study reveals that 0.5 μg/mL CML-HSA induced TNFα production in RAW 264.7 cells [40,41,61]. This evidence concerns the gene TNF and chronic myelogenous leukemia, BCR-ABL1 positive.